Through the use of stringent criteria, researchers have successfully identified two CAR-T cell targets in AML that were previously unknown: CD86 and the colony-stimulating factor 1 receptor (CSF1R) (254, 255). Here, CSF1R is linked to acute myeloid leukemia.